61346-19-8 Usage
General Description
1,2-Dihydro-5-nitroindazol-3-one is a chemical compound with the molecular formula C8H6N4O3. It is a nitro-substituted heterocyclic compound that is often used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 1,2-DIHYDRO-5-NITROINDAZOL-3-ONE is known for its potential as a mutagenic compound and is used in scientific research as a tool for studying the effects of certain chemical reactions. It is a yellow crystalline solid that is insoluble in water, but soluble in most organic solvents. 1,2-Dihydro-5-nitroindazol-3-one can be synthesized through various methods, including the nitration of indazole derivatives or the reduction of nitroindazole compounds. Its structure and properties make it an important building block for the synthesis of various organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 61346-19-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,3,4 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 61346-19:
(7*6)+(6*1)+(5*3)+(4*4)+(3*6)+(2*1)+(1*9)=108
108 % 10 = 8
So 61346-19-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H5N3O3/c11-7-5-3-4(10(12)13)1-2-6(5)8-9-7/h1-3H,(H2,8,9,11)
61346-19-8Relevant articles and documents
NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS
-
Page/Page column 40-41, (2012/12/13)
This invention relates to novel compounds which are inhibitors of acyl coenzymeA: diacylglycerol acyltransferase 1 (DGAT-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the prevention or treatment of diseases related to DGAT-1 dysfunction or where modulation of DGAT-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, hypertriglyceridemia, hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, hepatitis C virus infection and acne or other skin disorders.